CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Key Financials
Net Income
$-5995008
↓ 9.1%
Revenue
$6000
↓ 45.5%
EPS (Diluted)
$-2.52
↑ 32.1%
Operating Income
$-6142814
↓ 6.9%
Total Assets
$7.8M
↑ 17.1%
Shareholders' Equity
$7.5M
↑ 18.5%
Total Liabilities
$284880.00
↓ 13.1%
Gross Profit
$3806
↓ 42.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D | 10/1/2026 | View on SEC |
| 4 | 9/25/2026 | View on SEC |
| 8-K | 9/25/2026 | View on SEC |
| 8-K | 8/31/2026 | View on SEC |
| 10-Q | 8/7/2026 | View on SEC |
| 424B3 | 8/3/2026 | View on SEC |
| EFFECT | 7/31/2026 | View on SEC |
| S-3 | 7/24/2026 | View on SEC |
| DEF 14A | 7/14/2026 | View on SEC |
| 8-K | 7/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CELZ |
| Company Name | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. |
| CIK | 1187953 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 480-399-2822 |